Join an Event:
MMRF Endurance Events - Why Join Our Team
Why Join Our Team
What is Multiple Myeloma?
Multiple Myeloma is an incurable blood cancer that originates in plasma cells. It is the most common type of white blood cell cancer and the second most common blood cancer. Although progress has been made in treating multiple myeloma, the five-year relative survival rate remains one of the lowest of all cancers. In 2010, more than 20,000 adults in the United States were diagnosed with multiple myeloma and an estimated 11,000 people died from the disease.
Who is the MMRF?
The Multiple Myeloma Research Foundation (MMRF) was founded in 1998 as a 501 (c) 3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy was diagnosed with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to extend the lives of patients and lead to a cure.
As the world's number-one private funder of multiple myeloma research, the MMRF has raised over $160 million since its inception to fund more than 120 laboratories worldwide. An outstanding 90% of funds raised go toward research and related programming.
The MMRF is making a difference now — not only by fast tracking treatments for myeloma, but for other cancers as well. In recent years four new treatment advances — Thalomid®, Velcade®, Revlimid®, and Doxil® — have helped extend the life expectancy of myeloma patients from four years to almost seven. Because of their success in treating multiple myeloma patients, these drugs are now being explored as treatment for 30 other cancers too.
Why Join our Team?
Fulfill a dream and make the difference. The MMRF PowerTeam members take their love of sport and use that to raise funds to accelerate research that is helping to extend the lives of myeloma patients and will ultimately lead to a cure. Many members of our teams have a direct connection to multiple myeloma. Others work in the medical, research or pharmaceutical industry. A growing group of team members join us because they are inspired to support an amazing foundation that is transforming the way medical research and drug development are being conducted. They want to be a part of an organization that is making the difference in cancer research.
MMRF CEO named TIME Magazine’s 100 Most Influential People in the World
Congratulations to MMRF Founder and CEO , Kathy Giusti, who was named one of the world’s 100 most influential people by Time.
MMRF CEO Kathy Giusti Interviewed on CBS Evening News!
MMRF Founder and CEO Kathy Giusti was profiled on CBS Evening News with Katie Couric. In this special feature, Kathy discussed the MMRF’s progress in bringing patients with multiple myeloma next-generation treatments that are extending lives. Watch the video.
The Money Chase: Inside Harvard Business School
Documentary profiling Kathy Giusti
Kathy Giusti/ MMRF profile story, New Canaan Magazine
As evidence of the MMRF's exceptional fiscal responsibility, the MMRF has earned an A+ rating from the American Institutes of Philanthropy, a four-star rating from Charity Navigator, compliance with the Better Business Bureau's (BBB) Wise Giving Alliance standards for charity accountability, and approval from the National Cancer Institute for it research grant program. The MMRF is the world's only non-profit organization to have been recognized with all of these prestigious designations.